Marta Līva Spriņģe

Marta Līva Spriņģe

Auto-generated profile, based on publicly available information

Marta Līva Spriņģe

Department of Molecular and Functional Genomics, Latvian Biomedical Research and Study Centre, Riga, LV-1067, Latvia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
MSMarta Līva Spriņģe
Marta Līva Spriņģe
KVKristīne Vaivode
Kristīne Vaivode
RSRihards Saksis
Rihards Saksis
NVNineļa Miriama Vainšeļbauma
Nineļa Miriama Vainšeļbauma
LALaura Ansone
Laura Ansone
VRVita Rovite
Vita Rovite
Long-COVID affects at least 10% of COVID-19 survivors, displaying debilitating symptoms across multiple organ systems. Despite the increasing prevalence, the underlying causes remain unclear. This study presents a unique analysis of the PBMC transcriptomic landscape of COVID-19 and Long-COVID patients at a single-cell resolution. We reconstructed the cell state and communication using differentially expressed gene profiling and ligand-receptor interaction analyses. Our results reveal altered T and NK cell subset proportions, diminished proliferating lymphocyte and B cell signalling capacity, and the expression of exhaustion and cytotoxicity associated genes 1.5 – 2 years post-infection, suggesting incomplete immune recovery. Collectively, these findings provide insights into the immune processes underlying the progression of COVID-19 into a chronic Long-COVID state.

1 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
HNHelvijs Niedra
Helvijs Niedra
MSMarta L. Springe
Marta L. Springe
KTKatrine Tiltina
Katrine Tiltina
RPRaitis Peculis
Raitis Peculis
RSRihards Saksis
Rihards Saksis
VRVita Rovite
Vita Rovite
Neuroendocrine tumors are graded and classified largely by tumor cell-intrinsic features, yet the stromal microenvironment remains poorly defined across anatomical sites. We applied near single-cell spatial transcriptomics augmented with cell segmentation to eight treatment-naive neuroendocrine tumor primary tissues from pancreas, colon, appendix, and bile duct to build a spatially resolved stromal reference. Integration of stromal-enriched cell polygons identified ten transcriptional states shared across tumors, with a minority of niche-restricted clusters mapping to tumor/stroma and stroma/non-tumor boundaries. Within the shared fibroblast compartment, program scoring resolved four cancer-associated fibroblast states. Myofibroblastic and complement-secretory states dominated across samples, whereas inflammatory and antigen-presenting programs were consistently detected but weaker. Spatial mapping in desmoplastic tumors showed myofibroblastic fibroblasts enriched in collagen-dense regions, while complement-secretory fibroblasts localized preferentially to tumor-adjacent stromal interfaces. Pseudobulk differential expression and gene set enrichment analyses supported extracellular matrix remodeling in myofibroblastic fibroblasts and complement cascade activation in complement-secretory fibroblasts. Together, these findings demonstrate that anatomically distinct neuroendocrine tumors share a conserved yet spatially segregated stromal architecture, characterized by dominant matrix-producing and complement-enriched fibroblast states.